Colgate-Palmolive (NYSE:CL) Shares Sold by Sivia Capital Partners LLC

Sivia Capital Partners LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,391 shares of the company’s stock after selling 116 shares during the period. Sivia Capital Partners LLC’s holdings in Colgate-Palmolive were worth $224,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Piscataqua Savings Bank lifted its holdings in shares of Colgate-Palmolive by 1.3% in the 1st quarter. Piscataqua Savings Bank now owns 12,254 shares of the company’s stock valued at $1,148,000 after buying an additional 158 shares during the period. Gateway Investment Advisers LLC lifted its holdings in shares of Colgate-Palmolive by 18.7% in the 1st quarter. Gateway Investment Advisers LLC now owns 14,085 shares of the company’s stock valued at $1,320,000 after buying an additional 2,221 shares during the period. Stokes Capital Advisors LLC lifted its holdings in Colgate-Palmolive by 3.8% in the first quarter. Stokes Capital Advisors LLC now owns 68,949 shares of the company’s stock valued at $6,461,000 after acquiring an additional 2,516 shares during the period. KFG Wealth Management LLC lifted its holdings in Colgate-Palmolive by 1.5% in the first quarter. KFG Wealth Management LLC now owns 8,835 shares of the company’s stock valued at $828,000 after acquiring an additional 131 shares during the period. Finally, Congress Asset Management Co. lifted its holdings in Colgate-Palmolive by 7.0% in the first quarter. Congress Asset Management Co. now owns 160,133 shares of the company’s stock valued at $15,004,000 after acquiring an additional 10,414 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CL shares. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. Wells Fargo & Company upped their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a report on Wednesday, April 2nd. Barclays decreased their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating on the stock in a report on Friday, April 11th. UBS Group increased their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a “buy” rating in a report on Thursday, April 17th. Finally, Piper Sandler reduced their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Monday, March 31st. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $102.12.

Colgate-Palmolive Price Performance

NYSE:CL opened at $90.18 on Monday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market cap of $73.08 billion, a PE ratio of 25.62, a P/E/G ratio of 4.20 and a beta of 0.38. The stock has a 50 day moving average price of $91.77 and a 200 day moving average price of $91.15.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter last year, the firm earned $0.86 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. Equities research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were given a dividend of $0.52 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.31%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive announced that its Board of Directors has initiated a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.